Trial · NCT07899437
Code Blue: Status and Barriers in Egypt.
NCT07899437, Completed, National Hepatology & Tropical Medicine Research Institute
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Code Blue: Status and Barriers in Egypt. Trials, record NCT07899437. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899437
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Code Blue: Status and Barriers in Egypt.
- NCT number
- NCT07899437
- Status
- Completed
- Enrollment
- 110 participants, actual
- Lead sponsor
- National Hepatology & Tropical Medicine Research Institute
- Conditions
- Identify Existing Gaps, Code Blue Systems Organization and Implementation Remain Heterogeneous, and no National Data Are Available on Their Current Status
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Perceived effectiveness | immediately after the survey completion | Perceived overall effectiveness of the Code Blue system |
| Secondary | Availability and organizational characteristics of Code Blue systems | immediately after the survey completion | by asking about the presence and duration of the implementation of the code blue system in the hospital |
| Secondary | Code Blue team structure and readiness | immediately at the time of the survey | by asking about the 24/7 availability of trained, competent team |
| Secondary | Training and preparedness of Code Blue personnel | immediately after the survey completion | By asking about mandatory BLS/ALS training |
| Secondary | Documentation, auditing | immediately at the time of the survey | by asking about the documentation of Code Blue events and recording of response time, survival to discharge, and neurological outcomes, as well as post-event debriefing and regular case auditing. |
| Secondary | Monitoring of quality indicators | immediately at the time of the survey | by asking about response time, time to first defibrillation, CPR quality, ROSC, survival to discharge, and neurological outcomes. |
| Secondary | Barriers against effective implementation | immediately after the survey completion | By asking about the presence of staffing, training, communication, delayed response, equipment availability, hospital support, funding, workload, and the presence of written policies. |
| Secondary | Healthcare professionals' recommendations for strengthening | immediately after the survey completion | by asking about the best choice (one/or more); national guidelines, mandatory BLS/ALS certification, a national Code Blue registry, digital reporting, mandatory mock codes, and national accreditation standards. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899437
GET https://conductscience.org/api/trials/v1/NCT07899437/registered